Schizophreniform Disorder

Explore clinical trials studying Schizophreniform Disorder. Study availability and eligibility vary by location and protocol.

57 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Schizophreniform Disorder trial results

Completed

PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders

NCT00399334

Conditions: Disease Attributes, Mental Disorders, Pathologic Processes, +7 more
Locations: Not specified

View Trial Details

Completed

Study of Amantadine for Weight Stabilization During Olanzapine Treatment

NCT00287352

Conditions: Mental Disorders, Mood Disorders With Psychotic Features, Psychotic Disorder, +5 more
Locations: University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia

NCT00847600

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorders, +3 more
Locations: Shaar Menashe MHC and Tirat Carmel MHC Hadera, Israel

View Trial Details

Completed

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

NCT00749970

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +3 more
Locations: Research Site Alicante, Spain

Research site Barcelona, Spain

Research site Burgos, Spain

Research Site Córdoba, Spain

View all 14 locations

View Trial Details

Completed

An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.

NCT00391261

Conditions: Autism Spectrum Disorder, Autism Spectrum Disorders, Bipolar Disorder, +20 more
Locations: Cambridge Health Alliance Medford, Massachusetts, United States

View Trial Details

Completed

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

NCT00337662

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +3 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Escondido, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Garden Grove, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Glendale, California, United States

View all 34 locations

View Trial Details

Completed

The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

NCT00206557

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +3 more
Locations: Alfred Psychiatry Research Centre, Alfred Hospital Melbourne, Victoria, Australia

View Trial Details

Schizophreniform Disorder

Schizophreniform Disorder trial results

PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders

Study of Amantadine for Weight Stabilization During Olanzapine Treatment

Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

Related conditions